目的探讨淋巴细胞为主型乳腺癌(lymphocyte-predominant breast cancer,LPBC)中程序性死亡配体-1(programmed death-ligand 1,PD-L1)、CD163和CD8的表达和预后价值,并比较原发癌和相应淋巴结转移癌中PD-L1、CD163和CD8的表达。方法收集...
目的探讨富于淋巴细胞型乳腺癌(lymphocyte-predominant breast cancer,LPBC)中程序性死亡配体-1(programmed death ligand-1,PD-L1)和CD8^(+)肿瘤浸润淋巴细胞(tumor-infiltrating lymphocytes,TILs)在肿瘤中不同部位的表达与临床病理...